ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

RISANKIZUMABUM

Active substance (INN) · ATC L04AC18 · 6 products authorised in Romania
◀ Back
1

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

CodeProtocolStatusRoleSublistGP
L040M ARTRITA PSORIAZICĂ – AGENŢI BIOLOGICI: ADALIMUMABUM**1 (ORIGINAL ŞI BIOSIMILAR), CERTOLIZUMABUM**1, ETANERCEPTUM**1 (ORIGINAL ŞI BIOSIMILAR), GOLIMUMABUM**1, INFLIXIMABUM… In force medicine of the protocol C1-G31C NO
L034K BOALĂ CRONICĂ INFLAMATORIE INTESTINALĂ In force mentioned in the text C1-G31.A NO*
L044L PSORIAZIS CRONIC SEVER (ÎN PLĂCI) - AGENŢI BIOLOGICI ŞI TERAPII CU MOLECULE MICI CU ACŢIUNE INTRACELULARĂ In force mentioned in the text C1-G31F YES
2

History: entries into and exits from protocols

MonthTypeCodeProtocolLevel
April 2026Medicine added L034KBOALĂ CRONICĂ INFLAMATORIE INTESTINALĂ mentioned in the text
January 2026Medicine added L040MARTRITA PSORIAZICĂ – AGENŢI BIOLOGICI: ADALIMUMABUM**1 (ORIGINAL ŞI BIOSIMILAR), CERTOLIZUMABUM**1, ETANERCEPTUM**1 (ORIGINAL ŞI BIOSIMILAR) medicine of the protocol
3

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand nameFormStrengthHolderATCRx
SKYRIZI 150 mgSOL. INJ. IN SERINGA PREUMPLUTA150mg/1mlABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIAL04AC18PR
SKYRIZI 150 mgSOL. INJ. IN STILOU INJECTOR PREUMPLUT150mg/1mlABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIAL04AC18PR
SKYRIZI 180 mgSOL INJ. IN CARTUS150mg/mlABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIAL04AC18PR
SKYRIZI 360 mgSOL INJ. IN CARTUS150 mg/mlABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIAL04AC18PR
SKYRIZI 55 mgSOL. INJ. IN SERINGA PREUMPLUTA55mg/037mlABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIAL04AC18PR
SKYRIZI 600 mgCONC. PT. SOL. PERF.60 mg/mlABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIAL04AC18PR
SKYRIZI 75 mgSOL. INJ. IN SERINGA PREUMPLUTA75mg/0,5mlABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIAL04AC18PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.